Current status of anticoccidial drug resistance in China
10.16250/j.32.1915.2024147
- VernacularTitle:我国抗鸡球虫药物耐药性现状
- Author:
Yidan BAI
1
;
Wenting LI
1
;
Wanxin LUO
1
;
Yuxin YU
1
;
Dongfang LI
1
;
Junlong ZHAO
1
;
Lan HE
1
Author Information
1. College of Animal Science & Technology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China
- Publication Type:Journal Article
- Keywords:
Coccidia;
Anticoccidial agent;
Drug resistance;
Polyether ionophore;
Chemical synthesis
- From:
Chinese Journal of Schistosomiasis Control
2025;37(2):217-222
- CountryChina
- Language:Chinese
-
Abstract:
Avian coccidiosis, an acute parasitic disease that mainly harms chicks, is widely prevalent across the world, which poses a serious threat to poultry industry. Because of the single prophylactic formulations, veterinary clinical treatment of coccidiosis mainly relies on chemically synthesized agents, polyether ionophores and Chinese herbal medicines. The introduction of novel anticoccidial drugs is slow for a long period of time, and there is an increasing problem of anticoccidial drug resistance following long-term use, which has become an urgent problem to be solved in poultry industry. This review summarizes the levels of anticoccidial drug resistance across China from 2018 to 2023, and analyzes the resistance to various anticoccidial agents in coccidia. It is indicated that the overall prevalence of anticoccidial drug resistance is high in coccidia, and development of novel anticoccidial agents and products with reduced antibiotics use and alternatives of antibiotics is of an urgent need.
